Skip to main content

Animations

MJFF Publications

3981 - 3990 of 8824 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022
    Citation Count: 17
  • Summary Details
    OPEN
    Title: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029
    Citation Count: 23
  • Summary Details
    OPEN
    Title: The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.011
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Genetic characterization of Parkinson's disease patients in Ecuador and Colombia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.020
    Citation Count: 19
  • Summary Details
    OPEN
    Title: A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.020
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease motor subtypes and bilateral GPi deep brain stimulation: One-year outcomes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.004
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentary
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.